Literature DB >> 9284070

Distribution and postnatal ontogeny of adenosine A2A receptors in rat brain: comparison with dopamine receptors.

B Johansson1, V Georgiev, B B Fredholm.   

Abstract

In adult rat brain, adenosine A2A receptors and dopamine D2 receptors are known to be located on the same cells where they interact in an antagonistic manner. In the present study we wanted to examine when this situation develops and compared the postnatal ontogeny of the binding of the adenosine A2A receptor agonist [3H]CGS 21680, the binding of the dopamine D1 receptor antagonist [3H]SCH 23390 and the dopamine D2 receptor antagonist [3H]raclopride. All three radioligands bound to the striatum at birth and this binding increased several-fold during the postnatal period. [3H]SCH 23390 binding developed first (mostly during the first week), followed by [3H]raclopride binding (first to third week) and [3H]CGS 21680 binding (only during second and third week). For all three radioligands the binding tended to decrease between 21 days and adulthood. This occurred earlier and was more pronounced in the globus pallidus than in the other examined structures. The increase in [3H]CGS 21680 binding from newborn to adult was mainly due to four-fold increase in the number of binding sites. The pharmacology of [3H]CGS 21680 binding to caudate-putamen was similar in newborn, one-week-old and adult animals, and was indicative of A2A receptors. The binding was inhibited by guanylyl imidodiphosphate at all ages, indicating that A2A receptors are G-protein-coupled already at birth. In contrast to the large increase in [3H]CGS 21680 binding, there was a decrease in the levels of A2A messenger RNA during the postnatal period in the caudate-putamen. In cerebral cortex [3H]CGS 21680 bound to a different site than the A2A receptor. From birth to adulthood cortical binding of [3H]CGS 21680 increased four-fold and that of the adenosine A1 agonist [3H]cyclohexyladenosine 19-fold. During early postnatal development [3H]SCH 23390 binding was higher in deep than in superficial cortical layers, but this difference disappeared in adult animals. There was binding of both [3H]CGS 21680 and [3H]cyclohexyladenosine to the olfactory bulb, suggesting a role of the two adenosine receptors in processing of olfactory information. [3H]CGS 21680 binding was present in the external plexiform layer and glomerular layer, and increased during development, but the density of binding sites was about one tenth of that seen in caudate putamen. [3H]cyclohexyladenosine showed a very different labelling pattern, resembling that observed with [3H]SCH 23390. Postnatal changes in adenosine receptors may explain age-dependent differences in stimulatory caffeine effects and endogenous protection against seizures. Since A2A receptors show a co-distribution with D2 receptors throughout development, caffeine may partly exert such actions by regulating the activity of D2 receptor-containing striatopallidal neurons.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9284070     DOI: 10.1016/s0306-4522(97)00143-7

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  26 in total

1.  Adenosine A(2A) receptor enhances GABA(A)-mediated IPSCs in the rat globus pallidus.

Authors:  T Shindou; A Mori; H Kase; M Ichimura
Journal:  J Physiol       Date:  2001-04-15       Impact factor: 5.182

2.  Functional uncoupling of adenosine A(2A) receptors and reduced responseto caffeine in mice lacking dopamine D2 receptors.

Authors:  N R Zahniser; J K Simosky; R D Mayfield; C A Negri; T Hanania; G A Larson; M A Kelly; D K Grandy; M Rubinstein; M J Low; B B Fredholm
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

3.  Neuroprotection induced by the adenosine A2A antagonist CSC in the 6-OHDA rat model of parkinsonism: effect on the activity of striatal output pathways.

Authors:  Jordi Bové; Jordi Serrats; Guadalupe Mengod; Roser Cortés; Eduardo Tolosa; Concepció Marin
Journal:  Exp Brain Res       Date:  2005-06-21       Impact factor: 1.972

Review 4.  Adenosine A2A receptors in ventral striatum, hypothalamus and nociceptive circuitry implications for drug addiction, sleep and pain.

Authors:  S Ferré; I Diamond; S R Goldberg; L Yao; S M O Hourani; Z L Huang; Y Urade; I Kitchen
Journal:  Prog Neurobiol       Date:  2007-05-01       Impact factor: 11.685

5.  The effects of adenosine A2A receptor antagonists on haloperidol-induced movement disorders in primates.

Authors:  Geoffrey B Varty; Robert A Hodgson; Annamarie J Pond; Michael E Grzelak; Eric M Parker; John C Hunter
Journal:  Psychopharmacology (Berl)       Date:  2008-07-03       Impact factor: 4.530

6.  GPR88 - a putative signaling molecule predominantly expressed in the striatum: Cellular localization and developmental regulation.

Authors:  Vincent Van Waes; Kuei Y Tseng; Heinz Steiner
Journal:  Basal Ganglia       Date:  2011-07-01

7.  Pharmacologic neuroimaging of the ontogeny of dopamine receptor function.

Authors:  Y Iris Chen; Ji-Kyung Choi; Haibo Xu; Jiaqian Ren; Susan L Andersen; Bruce G Jenkins
Journal:  Dev Neurosci       Date:  2010-06-03       Impact factor: 2.984

8.  Developmental increase in ecto-5'-nucleotidase activity overlaps with appearance of two immunologically distinct enzyme isoforms in rat hippocampal synaptic plasma membranes.

Authors:  Ivana Grkovic; Ivana Bjelobaba; Nadezda Nedeljkovic; Natasa Mitrovic; Dunja Drakulic; Milos Stanojlovic; Anica Horvat
Journal:  J Mol Neurosci       Date:  2014-02-22       Impact factor: 3.444

Review 9.  An essential role for adenosine signaling in alcohol abuse.

Authors:  Christina L Ruby; Chelsea A Adams; Emily J Knight; Hyung Wook Nam; Doo-Sup Choi
Journal:  Curr Drug Abuse Rev       Date:  2010-09

10.  Adenosine A1 receptor activates background potassium channels and modulates information processing in olfactory bulb mitral cells.

Authors:  Natalie Rotermund; Svenja Winandy; Timo Fischer; Kristina Schulz; Torsten Fregin; Nadine Alstedt; Melanie Buchta; Janick Bartels; Mattias Carlström; Christian Lohr; Daniela Hirnet
Journal:  J Physiol       Date:  2018-01-24       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.